Embolization and chemoembolization therapy for neuroendocrine tumors
Author:
- 1 January 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 11 (1) , 38-41
Abstract
Neuroendocrine tumors, particularly those of gastrointestinal tract origin, have a predisposition for metastasizing to the liver. In such patients, the clinical course is often dominated by the hepatic disease, either because of hormone secretion or because of tumor bulk. Because the liver has a dual vascular supply and hepatic metastases derive the majority of blood from the hepatic artery, the regional delivery of chemotherapy can offer pharmacokinetic advantages over systemic administration. The hepatic artery is also a nonsurgical avenue for inducing selective metastasis ischemia by the embolization of tumor vessels. The combination of these two therapies, or chemoembolization, may provide additive benefits. Such an approach has been demonstrated to reduce tumor bulk, reduce hormone levels, and palliate the symptoms of many patients with liver-dominant neuroendocrine metastases. Embolization or chemoembolization is an appropriate modality for some patients with neuroendocrine tumors.Keywords
This publication has 27 references indexed in Scilit:
- A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 1995
- Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastasesCancer, 1991
- Hepatic arterial embolization for metastatic hormone-secreting tumors technique, effectiveness, and complicationsCancer, 1990
- Pharmacokinetics of Intra-Arterial Mitomycin C With or Without Degradable Starch Microspheres (DSM) in the Treatment of Non-Resectable Liver CancerActa Oncologica, 1989
- Metastatic carcinoid tumors and the carcinoid syndrome: A selective review of chemotherapy and hormonal therapyThe American Journal of Medicine, 1986
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- The carcinoid syndrome: palliation by hepatic artery embolizationAmerican Journal of Roentgenology, 1986
- Role of hepatic arterial embolisation in the carcinoid syndrome.BMJ, 1983
- Hepatic artery ligation and postoperative chemotherapy for hepatic metastases: Clinical and pathophysiological resultsCancer, 1975
- Arteriography in the Diagnosis of Islet-Cell TumorsRadiology, 1970